A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Clinical trial NCT03861481 · COMPLETED
Trial details
- NCT number
- NCT03861481
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-26
- Primary completion
- 2021-03-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.